Jan 20 (Reuters) - Three months ended Dec. 31
(Versus the same period a year earlier, in million rupees unless stated)
Net profit 1,007.5 vs 808.9
Net sales 7,280.5 vs 6,351.2
NOTE: Biocon (BION.BO) is India’s top listed biotechnology firm. The numbers are consolidated.
On a standalone basis, net profit for the quarter was 2.12 billion rupees. (Reporting by Bharghavi Nagaraju; editing by Malini Menon)